NVIDIA Corporation (NASDAQ: NVDA) is scheduled to report third quarter 2020 earnings results on Thursday, November 14, after the market closes. Analysts expect the company to report earnings of $1.58 per share on revenue of $2.92 billion. This compares to earnings of $1.84 per share on revenue of $3.18 billion.
Nvidia has struggled with lower demand for graphic cards following a slump in the cryptocurrency space. The company has seen weak revenues in its gaming and data center businesses over the past two quarters. However, the demand in gaming chips could have picked up during the third quarter helped by new products and technologies.
The demand for data center components seems to have also gained momentum during the quarter and this is likely to help the topline results. NVIDIA’s investments in artificial intelligence capabilities also bode well as there is increasing growth potential in this space.
In the second quarter of 2020, NVIDIA reported revenue and earnings that were lower versus the previous year but ahead of Street expectations. Revenue dropped 17% to $2.58 billion, hurt by weakness in the data center and GPU businesses. Adjusted EPS fell 36% to $1.24.
Also read: NVIDIA Q2 2020 Earnings Conference Call Transcript
For the third quarter, NVIDIA has guided for revenues of $2.90 billion, plus or minus 2%. Adjusted gross margin is expected to be 62.5%, plus or minus 50 basis points. Adjusted operating expense is forecast to be approx. $765 million.
Shares of NVIDIA have gained 57% year-to-date and 36% over the past three months. The majority of analysts have rated the stock as Buy and it has an average 12-month price target of $201.83.
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company